Sanofi is jumping into the Rituxan biosimilars fray in a potential $200 million-plus deal with JHL Biotech, putting the Taiwan-based drugmaker's new China…

Valeant's business relationships with its distributors are under scrutiny once again, with the latest probe focusing on the remarkable sales performance…

Pamplona, Spain-based Idifarma announced Monday that Suanfarma, an API producer based in Madrid, had bought out some of the venture capital investors who…

China’s Zhejiang Hisun Pharmaceutical has gotten in progressively hotter water with the FDA, but its troubles have not kept it from striking deals globally…

Merck KGaA wants to be a go-to company to help others develop and manufacture gene-related therapies and will expand its campus in Carlsbad, CA, by nearly 50%…

Despite a stumbling economy in recent years, Russia still holds a lot of appeal as an emerging market for drugmakers. Japan's Eisai is planning a major…

By year-end, the United Arab Emirates (UAE) can expect to have a new manufacturing plant producing drugs for the country as a Saudi drugmaker completes the…

It was just 6 months ago that vaccines specialist CSL closed on its $275 million buyout of Novartis' influenza vaccines operations, getting three…